218 related articles for article (PubMed ID: 20140970)
1. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole.
Li L; Fang L; Xu X; Liu Y; Sun Y; He Z
Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970
[TBL] [Abstract][Full Text] [Related]
2. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z
Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718
[TBL] [Abstract][Full Text] [Related]
3. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
4. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
6. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
7. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
8. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.
Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ
J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172
[TBL] [Abstract][Full Text] [Related]
10. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of ubidecarenone transdermal delivery systems.
Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
[TBL] [Abstract][Full Text] [Related]
12. Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: In vitro and in vivo evaluations.
Jung E; Lee EY; Choi HK; Ban SJ; Choi SH; Kim JS; Yoon IS; Kim DD
Int J Pharm; 2015 Jun; 487(1-2):49-55. PubMed ID: 25863117
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo and in vivo evaluation of transdermal formulation of trazodone hydrochloride.
Das MK; Ghosal SK
Acta Pol Pharm; 2008; 65(4):481-6. PubMed ID: 19051591
[TBL] [Abstract][Full Text] [Related]
14. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
16. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
Rhee YS; Nguyen T; Park ES; Chi SC
Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Pharmacokinetic Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Koumine.
Su Y; Lu W; Fu X; Xu Y; Ye L; Yang J; Huang H; Yu C
AAPS PharmSciTech; 2020 Oct; 21(8):297. PubMed ID: 33099696
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a monolithic drug-in-adhesive patch for valsartan.
Nishida N; Taniyama K; Sawabe T; Manome Y
Int J Pharm; 2010 Dec; 402(1-2):103-9. PubMed ID: 20933069
[TBL] [Abstract][Full Text] [Related]
19. Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
Park CW; Son DD; Kim JY; Oh TO; Ha JM; Rhee YS; Park ES
Int J Pharm; 2012 Oct; 436(1-2):32-40. PubMed ID: 22771734
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro evaluation of pentazocine transdermal delivery system.
Furuishi T; Io T; Fukami T; Suzuki T; Tomono K
Biol Pharm Bull; 2008 Jul; 31(7):1439-43. PubMed ID: 18591789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]